La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes

Laboratoires Industriels de Vichy (LIDV)

Drug Facts


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active ingredients

Octinoxate 7.5%

Titanium dioxide 5.6%

Uses Directions

Uses

  • helps prevent sunburn
  • higher SPF gives more sunburn protection
  • protects against UVA/UVB rays

Directions

  • apply evenly before sun exposure and as needed
  • children under 6 months of age: ask a doctor

Warnings

Warnings

For external use only

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash or irritation develops and lasts

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes

La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes

Octinoxate Titanium dioxide LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:66382-157
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 1.125 mL
titanium dioxide 1.14 mL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 15 in 1 TUBE
2 NDC:66382-157-01 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2009-09-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.